Page last updated: 2024-10-23

aspirin and Multiple Chronic Conditions

aspirin has been researched along with Multiple Chronic Conditions in 1 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Multiple Chronic Conditions: Two or more concurrent chronic physical, mental, or behavioral health problems in an individual.

Research Excerpts

ExcerptRelevanceReference
"Patients with coronary artery disease (CAD) presenting with acute coronary syndrome or undergoing coronary stenting are indicated to treatment with dual antiplatelet therapy (DAPT) combining aspirin with a P2Y12 receptor inhibitor."5.12Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients. ( Costa, F; Fischman, D; Sabouret, P; Savage, MP, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sabouret, P1
Savage, MP1
Fischman, D1
Costa, F1

Reviews

1 review available for aspirin and Multiple Chronic Conditions

ArticleYear
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:1

    Topics: Aspirin; Coronary Artery Disease; Hemorrhage; Humans; Multiple Chronic Conditions; Platelet Aggregat

2021